Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer

NCT00255788 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: everolimus

Sponsor

NCIC Clinical Trials Group